Showing 391-400 of 855 results for "".
- Delnova Demonstrates Proof of Concept for ReViVoxhttps://modernaesthetics.com/news/delnova-demonstrates-proof-of-concept-for-revivox/2473478/Delnova’s ReViVox showed reversal or muscle paralysis or weakness in a small cohort of healthy subjects. ReViVox is being developed to resolve side effects that may result from botulinum neurotoxin treatments. In the proof-of-concept study, volunteer subj
- New Skin-Responsive FUE Technique Improves Hair Restoration Results Among Individuals of African Descent,https://modernaesthetics.com/news/new-skin-responsive-fue-technique-improves-hair-restoration-results-among-individuals-of-african-descent/2473468/A new follicular unit excision (FUE) device may improve hair restoration results among individuals of African descent, according to a study in Dermatologic
- L'Oréal CEO to Deliver Keynote at CES 2024https://modernaesthetics.com/news/loreal-ceo-to-deliver-keynote-at-ces-2024/2473457/L'Oréal CEO Nicolas Hieronimus will deliver the first-ever keynote from a beauty company at CES 2024. L'Oréal's keynote will showcase the role that sustainable, accessible and inclusive beauty tech plays in driving positive impact at an individu
- FDA Warns of Risk for Delayed-onset Inflammation Near Dermal Filler Siteshttps://modernaesthetics.com/news/us-fda-warns-of-risk-for-delayed-onset-inflammation-near-dermal-filler-sites/2473443/The US Food and Drug Administration updated its informational webpage on dermal fillers to reflect
- WCD News: Deka Rolls Out Three New Laser and Microwave Platformshttps://modernaesthetics.com/news/wcd-news-deka-rolls-out-three-new-laser-and-microwave-platforms/2473441/DEKA is launching of its new PRO line at the 25th World Congress of Dermatology in Singapore. Based on laser and microwave technology, the line includes the Again PRO, RedTouch PRO, and Onda PRO platforms. The Again PRO platform, a combinatio
- It's Camp Time for Dermatologistshttps://modernaesthetics.com/news/its-camp-time-for-dermatologists/2473432/As kids across the country got ready for summer camp, dermatologists flocked to Brooklyn, NY, for their own version of summer camp: Neutrogena’s immersive SkinU Summer Camp. Instead of learning to swim, sliding down a zipline, or playing tennis like kids in camp oft
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou